A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates – mostly in Africa, Southeast Asia and the Caribbean. But it has excluded nearly all of Latin America, where rates are far lower but increasing, sparking concern the world is missing a critical opportunity to stop the disease., Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates – mostly in Africa, Southeast Asia and the Caribbean. But it has excluded nearly all of Latin America, where rates are far lower but increasing, sparking concern the world is missing a critical opportunity to stop the disease., , Read More